Stock

Showing 7 posts of 7 posts found.

stock-exchange-911613_1920

Pharma stocks soar after US midterm elections

November 8, 2018
Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market

Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …

stocks

Galena’s breast cancer immunotherapy fails in late-stage trials; shares plunge

June 30, 2016
Research and Development, Sales and Marketing Galena Biopharma, Stock, breast cancer, drug trial

Shares in Galena Biopharma (Nasdaq: GALE) dropped over 80% after the company said an independent Data Monitoring Committee recommended that …

stocks1

Weekly Movers: Relypsa, Titan Pharma, Allergan…

June 6, 2016
Research and Development, Sales and Marketing Stock, drug trial, research, stock market

The prestigious ASCO meet is underway and results of new drug trials will be a key stock mover over the …

stocks1

Weekly Movers: XenoPort, Akari, Bayer…

May 31, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Sarepta Therapeutics, Stick Market, Stock, Xenoport, finance

Bayer-Monsanto story comes close on the heels of Sanofi-Medivation tussle as the pharma sector goes through the motions of consolidation. …

stocks3

Aduro’s pancreatic cancer immunotherapy fails Phase II trials; shares plunge

May 17, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets

Shares in Aduro Biotech (Nasdaq: ADRO) dropped to closed down over 16% after the company said mid-stage trials of its …

stocks1

Weekly Movers: Teva, Midatech, Allergan…

May 16, 2016
Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets

We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …

pfizer_building

Pfizer enters $5 billion share buyback deal with Goldman Sachs

March 9, 2016
Business Services, Research and Development Pfizer, Share buyback, Stock, markets

US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …

Latest content